R&D and technology play an essential role in our firm. We invest in constant learning, testing and innovation. That uniquely positions us to solve our clients’ most difficult problems.
Innovation EngineOur CORE groups manage our research and development efforts, from incremental efficiency improvements to solving some of the most challenging engineering problems of our time.Learn More
Innovation OutputWe believe collaboration amplifies our innovation potential and creates connections that lead to better, more imaginative solutions for our clients.Learn More
Engineering decarbonization doesn’t stop at the building envelope. Discover how Thornton Tomasetti and Crozier Fine Arts are applying systems engineering and carbon modeling to reduce operational emissions across the global fine art supply chain.
As we approach the start of the 2023 Atlantic hurricane season, let’s take a look back at the 2022 season, as well as the developing El Niño, and learn what this means for the season to come.
It’s spring and that means baseball is back! At ballparks everywhere ground crews are prepping the turf and chalking the baselines as coaches finalize their starting lineups.
The use of hydrogen as a replacement for natural gas presents all of the hazards we associate with natural gas although the extent of the hazards can be greater for hydrogen; the flammability ranges in air for hydrogen are 4 % to 75 % by volume, high pressure releases of hydrogen can auto-ignite and hydrogen explosions can be more severe as hydrogen is more prone to detonation.
The medical device industry recognizes the general motivation for in silico trials. The CORE.AI project at Thornton Tomasetti aims to create an automated workflow for medical device in silico trials. In this work, the goal of the in-silico trial is to assess the efficacy and safety of a generic, representative thoracic stent graft for the treatment of a thoracic aortic aneurysm (TAA).